Viewing Study NCT06041269


Ignite Creation Date: 2025-12-24 @ 11:02 PM
Ignite Modification Date: 2026-01-25 @ 12:12 AM
Study NCT ID: NCT06041269
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-11-25
First Post: 2023-09-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Efficacy and Safety of Rosnilimab in Subjects with Moderate to Severe Rheumatoid Arthritis (RENOIR)
Sponsor: AnaptysBio, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Rheumatoid Arthritis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None PD-1 Agonist View
None ANB030 View
None RENOIR View
None Rosnilimab View